Current and historical daily PE Ratio for Santhera Pharmaceuticals Holding AG (
) from 2006 to May 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Santhera Pharmaceuticals Holding AG stock (XSWX:SANN) PE ratio as of May 11 2024 is 0.
More Details
Santhera Pharmaceuticals Holding AG (XSWX:SANN) PE Ratio (TTM) Chart
Santhera Pharmaceuticals Holding AG (XSWX:SANN) PE Ratio (TTM) Historical Data
View and export this data going back to 2006. Start your Free Trial
Total 1266
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Santhera Pharmaceuticals Holding AG PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-05-11 | At Loss | 2024-03-05 | At Loss |
2024-05-10 | At Loss | 2024-03-04 | At Loss |
2024-05-08 | At Loss | 2024-03-01 | At Loss |
2024-05-07 | At Loss | 2024-02-29 | At Loss |
2024-05-06 | At Loss | 2024-02-28 | At Loss |
2024-05-03 | At Loss | 2024-02-27 | At Loss |
2024-05-02 | At Loss | 2024-02-26 | At Loss |
2024-04-30 | At Loss | 2024-02-23 | At Loss |
2024-04-29 | At Loss | 2024-02-22 | At Loss |
2024-04-26 | At Loss | 2024-02-21 | At Loss |
2024-04-25 | At Loss | 2024-02-20 | At Loss |
2024-04-24 | At Loss | 2024-02-19 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
2024-04-12 | At Loss | 2024-02-07 | At Loss |
2024-04-11 | At Loss | 2024-02-06 | At Loss |
2024-04-10 | At Loss | 2024-02-05 | At Loss |
2024-04-09 | At Loss | 2024-02-02 | At Loss |
2024-04-08 | At Loss | 2024-02-01 | At Loss |
2024-04-05 | At Loss | 2024-01-31 | At Loss |
2024-04-04 | At Loss | 2024-01-30 | At Loss |
2024-04-03 | At Loss | 2024-01-29 | At Loss |
2024-04-02 | At Loss | 2024-01-26 | At Loss |
2024-03-28 | At Loss | 2024-01-25 | At Loss |
2024-03-27 | At Loss | 2024-01-24 | At Loss |
2024-03-26 | At Loss | 2024-01-23 | At Loss |
2024-03-25 | At Loss | 2024-01-22 | At Loss |
2024-03-22 | At Loss | 2024-01-19 | At Loss |
2024-03-21 | At Loss | 2024-01-18 | At Loss |
2024-03-20 | At Loss | 2024-01-17 | At Loss |
2024-03-19 | At Loss | 2024-01-16 | At Loss |
2024-03-18 | At Loss | 2024-01-15 | At Loss |
2024-03-15 | At Loss | 2024-01-12 | At Loss |
2024-03-14 | At Loss | 2024-01-11 | At Loss |
2024-03-13 | At Loss | 2024-01-10 | At Loss |
2024-03-12 | At Loss | 2024-01-09 | At Loss |
2024-03-11 | At Loss | 2024-01-08 | At Loss |
2024-03-08 | At Loss | 2024-01-05 | At Loss |
2024-03-07 | At Loss | 2024-01-04 | At Loss |
2024-03-06 | At Loss | 2024-01-03 | At Loss |
Santhera Pharmaceuticals Holding AG (XSWX:SANN) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Santhera Pharmaceuticals Holding AG
NAICS : 325414
ISIN : CH1276028821
Description